The effect of poly-g-glutamic acid (gPGA), which is produced by Bacillus sp., on the production of recombinant erythropoietin (rEPO) by Chinese hamster ovary (CHO) cells in suspension culture was evaluated. The growth, viability, and productivity of recombinant CHO cells were investigated in a chemically defined medium with 50 and 500 kD gPGAs at 0.075% or with Pluronic F68. Cell growth with the two gPGAs was lower than that with Pluronic F68 but significantly higher than that without any additive (control). The effect of additives on rEPO productivity was 50 kDa gPGA > 500 kDa gPGA > Pluronic F68 > control. Using EPO-dependent F-36E cells, we found that the effect of additives on rEPO quality was 500 kDa gPGA > 50 kDa gPGA > control > Pluronic F68. gPGA has an enhancement effect on the quality of rEPO produced by CHO cells.
Introduction
Cultivation of mammalian cells producing recombinant therapeutic protein is important for the biopharmaceutical market. [1] Chinese hamster ovary (CHO) cells are commonly used mammalian cells for large-scale production of recombinant proteins. Since CHO cells offer stable and accurate glycosylation, they provide more accurate processing of natural proteins in vitro. [2] From an industrial perspective, the ability of CHO cells to adapt and grow in suspension is highly desirable as it allows volumetric scalability and use of large stirredtank bioreactors with a serum-free medium. [3] Mammalian cells are particularly fragile; however, the presence of certain chemical additives (i.e., serum, pluronic alcohols, bovine serum albumin, and polyethylene glycol) can effectively reduce animal cell damage in suspension culture. [4] The most widely used protective medium additive, Pluronic F68, has been proven to support highdensities suspension culture of animal cells over time. [5] However, many problems have been reported with Pluronic F68, including reduced growth rate due to the lower rate of DNA synthesis in continuous and short-term cultures, [6] as well as decreased recombinant protein productivity under sublytic levels of shear stress. [7] For these reasons, other efficient medium additives to replace and/or complement Pluronic F68 need to be investigated. [8] Erythropoietin (EPO) is a 30.4 kDa glycoprotein and a haemopoietic hormone, which primarily stimulates the proliferation and differentiation of erythroid precursor cells in the treatment of renal and nonrenal anaemias. [9] Poly-g-glutamic acid (gPGA) is the most promising biodegradable polymer that is produced by Bacillus subtilis. gPGA is well characterized as water soluble, biodegradable, edible, and nontoxic in humans and the environment. [10] Previously, we have shown that gPGA could be an attractive alternative polymer for use as a medium additive to avoid shear stress damage during the cultivation of CHO DG44 cells. [11] However, it was not clear how the presence of gPGA affects the production and quality of proteins by CHO cells. In this study, we compared the effect of gPGA and Pluronic F68 medium additives on the productivity and quality enhancement of recombinant erythropoietin (rEPO) produced by CHO cells in a chemically defined medium.
Materials and methods

Cell line and cell culture
The recombinant human EPO-producing CHO cell line (EC2-2C5; rCHO) constructed by transfecting the cDNA encoding human EPO under the control of the cytomegalovirus promoter into DG44 CHO cells was kindly provided by Jung-Hoe Kim, KAIST (Taejon, Korea). The EC2-2C5 cell line was cultured as a monolayer in 14 mL of MEMa modification medium (WelGENE, Daegu, Korea) supplemented with 10% (v/v) dialysed FBS (SAFC Bioscience, Lenexa, KS, USA) and 20 nmol/L MTX in 75 cm 2 T-flasks. The cells were incubated at 37 C in a humidified 5% CO 2 atmosphere. Cell viability was determined by trypan blue dye exclusion with a haemocytometer.
Adaptation in suspension
The cells were adapted directly to suspension growth in a chemically defined medium for CHO cells (HyQCDM4CHO, Hyclone, Logan, UT, USA) supplemented with 2 nmol/L MTX in 125 mL Erlenmeyer flasks on a rotary shaker at 110 r/min. To investigate the effect of polymer additives, 30 mL of culture medium was supplemented with Pluronic F68 or gPGA at each concentration. For maintenance, cells were seeded at a concentration of 3 Â 10 5 cells/mL in fresh medium every 3 days. The growth rate (h À1 ) was calculated as follows [12] : m ¼ (1/x)(dx/dt), where m is the growth rate, dx is the increase in cell number, dt is the time interval, and x is the number of cells.
Preparation of medium additives
The medium additives were Pluronic F68, 50 kDa gPGA, and 500 kDa gPGA. Pluronic F68 was purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA) as a 10% (w/v) stock solution, and 50 kDa and 500 kDa gPGAs were supplied by Bioleaders (Daejeon, Korea). Each gPGA polymer powder was dissolved in HyQCDM4CHO medium at a concentration of 1% (w/v), and filtered with a 0.22 mm membrane, and adjusted to a pH of 7.0-7.2. The stock solutions were diluted in HyQCDM4CHO medium at the final concentrations of 0.05%, 0.075%, and 0.1%.
Measurement of rEPO production by immune assay
To measure the concentration of rEPO, 1 mL of culture media was collected from each culture suspension and centrifuged at 2500Â g for 5 min to obtain the supernatants. The expression levels of secreted rEPO were measured by Quantikine Human EPO Immunoassay kit (R&D Systems, Minneapolis, MN, USA) according to the supplier's instructions.
Bioassay of rEPO
The biological activity of rEPO in the culture medium was evaluated using F-36E, an EPO-dependent cell line, derived from the human bone marrow (RCB0776, RIKEN Cell Bank, Ibaraki, Japan). F-36E cells were maintained in RPMI 1640 (WelGENE) in the presence of EPO. [13] The supernatant from the culture medium with gPGAs or Pluronic F68 was frozen at À20 C before analysis. F-36E cells were inoculated at a cell density of 1 Â 10 4 cells per well in 96-well plates without EPO; the supernatant was then added to each well. After incubation for 3 days, cell viability was measured by the WST-1 assay.
Results and discussion
Adaptation of rCHO cells in suspension culture with polymer additives
The EPO-producing CHO cell line (rCHO) had been already adapted to Pluronic F68 during its development. When a new medium additive is introduced, CHO cells need to adapt to the new medium additive. Therefore, rCHO was adapted to 500 kDa gPGA at 0.075% for 36 days (Figure 1 ). The viable cell number with gPGA was about 33%-70% lower than that with 0.1% Pluronic F68 before day 16. However, the cell number with gPGA 
Effect of gPGA concentrations on cell growth and viability of rCHO cell suspension culture
To evaluate the effect of various concentrations of 50 and 500 kDa gPGAs on the protection of rCHO cells from shear stress, cell growth was investigated using a concentration of 0.05%, 0.075%, and 0.1% gPGAs. Both 50 and 500 kDa gPGAs at different concentrations favoured cell growth in the order of 0.075% > 0.05% > 0.1% (data not shown). No difference in cell growth was observed between 50 and 500 kD gPGA except on days 5 and 6 at 0.075% (Figure 3(A) ).
Effect of medium additives on cell growth and viability
To compare the effect of gPGAs and Pluronic F68, the cell growth and viability were measured in the presence of no additive (control), 50 and 500 kDa gPGAs at 0.075%, and 0.1% Pluronic F68 (Figure 3(A) ). On day 5, the cell density with Pluronic F68, 50 kDa PGAs, 500 kDa gPGAs, and control was 5.1 Â 10 6 , 4.3 Â 10 6 , 3.7 Â 10 6 , and 2.5 Â 10 6 cells/mL, respectively. Therefore, Pluronic F68 supported a higher cell density than gPGAs; however, gPGAs also supported a higher cell density than the control medium. This result is in contrast with our previous results with gPGAs, which demonstrated that gPGAs supported cell growth similar to Pluronic F68. [11] The difference is possibly due to the different CHO cell lineage. The viability of rCHO cells was similar among Pluronic F68 and both gPGAs, but lower in the control during cell growth (Figure 3(B) ).
Effect of medium additives on rEPO production
The effect of 0.075% gPGAs and 0.1% Pluronic F68 on the productivity of rCHO cells was investigated. To assay the cumulative concentration of rEPO, samples of the cell culture were obtained from each culture supernatant on days 5-7 ( Figure 4) . On day 5, rEPO concentrations with control, 50 kDa gPGAs, 500 kDa gPGAs, and Pluronic F68 were 8055, 6152, 7110, and 9.251 IU/mL, respectively. On day 6, rEPO concentrations with gPGAs of 50 and 500 kDa were 7646 and 8813 IU/mL, respectively. These values were lower than those of the control and Pluronic F68. However, on day 7, rEPO concentrations with 50 and 500 kDa gPGAs were 13,275 and 12,020 IU/mL -the values were 125% and 116% of Pluronic F68, respectively. Essentially no difference in the rEPO concentrations was observed between days 6 and 7 in the control or with Pluronic F68. The concentration of rEPO produced by the medium additives and the control on day 7 was in the order of 50 kDa gPGA > 500 kDa gPGA > Pluronic F68 > control (Figure 4 ).
Biological activity of rEPO produced in the presence of medium additives
The biological activity of rEPO with different culture media from days 6 and 7 was investigated using F-36E cells ( Figure 5 ). The F-36E cell viabilities (i.e., biological activities) were measured with culture media containing Pluronic F68 and 50 or 500 kDa gPGAs. The viabilities of F-36E cells with culture media containing gPGAs were higher than those with control and Pluronic F68. The viabilities with culture media containing 50 and 500 kDa gPGAs on day 6 were 114% and 127% of those in the control, respectively. The effect of medium additives on rEPO biological activities was in the order of 500 kDa gPGA > 50 kDa gPGA > control > Pluronic F68. Overall, the rEPO biological activities increased on day 7 but the difference in the biological activities decreased. Unexpectedly, the viabilities with Pluronic F68 were 89% and 84% of the control on days 6 and 7, respectively. These results showed that although growth with gPGAs was less than that with Pluronic F68, the concentration (with the exception of day 6) and biological activity of rEPO with gPGAs were significantly higher than those with Pluronic F68. 
Final remarks
In this study, two gPGAs of 50 and 500 kDa were employed to find the optimal molecular weight and concentration of gPGAs. The results showed that the cell growth was dependent upon both molecular weight and concentration of gPGAs for the productivity and biological activity of rEPO. Regardless of our positive results with gPGA in the production of rEPO, further studies are required for in situ application of gPGA, such as its application in large stirred-tank bioreactors using serum-free medium and in downstream processing such as harvest and purification. Our findings with gPGA may be applicable to other biopharmaceuticals.
Conclusions
To the best of our knowledge, we showed for the first time that a biologics, rEPO, can be produced by CHO cells in the presence of gPGA in place of Pluronic F68, and that CHO cells can be adapted to the presence of gPGA to be protected from shear stress during production of pharmaceuticals. Although Pluronic F68 gave a little higher CHO cells growth and amount of produced rEPO than gPGA, the quality of rEPO as measured by viability assay was higher with gPGA than with Pluronic F68. This also suggests that the use of gPGA instead of Pluronic F68 may be a suitable alternative to enhance the quality of rEPO produced by CHO cell suspension cultures.
